Study investigates the sustainability in blood pressure reduction through a 12-month lifestyle intervention

FHS
June 21, 2023
6:02 pm

The sustainability and scalability of limited duration interventions in low- and middle-income countries remain unclear.

Toripalimab by Shanghai Junshi Biosciences for Metastatic Colorectal Cancer: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

November 19, 2023

Weight-Loss Surgery Scandal; Unnecessary Vascular Surgeries; Private Equity Probe

Welcome to the latest edition of Investigative Roundup, highlighting some of the best investigative reporting on healthcare each week. Bariatric Surgery Assembly Line? Bellevue Hospital,

December 14, 2023

Biogen paring back research efforts; Will Chinese biotechs threaten US dominance?; What the new administration means for pharma ; and more

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

January 26, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.